Bayer has joined the throng of drugmakers developing KRAS-targeting therapies for cancer by licensing an early-stage candidate from Kumquat Biosciences. The deal – which has a total value of up to ...

Bayer's much-anticipated stem cell therapy for Parkinson's disease is gathering momentum, with dosing in phase 3 trials now underway. The first patient has already been treated with bemdaneprocel, a ...

Bayer Aktiengesellschaft remains deeply undervalued despite ongoing operational and litigation headwinds, supporting a bullish stance. Q3/25 results were weak, but technicals and intrinsic value ...

Heading into the second half of their 2025 financial year, Bayer leaders echo positive comments surrounding the company’s crop science division. What has them bullish? First, Bayer is optimistic the ...

The initial results from the Bayer Carbon Program are in – and they’re significant. According to Nori, a carbon removal issuing program, registry and marketplace, over 125,000 regenerative tonnes from ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

EU leaders will loan 90 billion euros to Ukraine, but fail to agree to use frozen Russian assets European Union leaders decided to borrow cash to loan $105 billion to Ukraine to fund its defence ...

Installing a smart meter could help you pay less for your energy, but not everyone is convinced by the technology. While gas and electricity prices today are far below their peak during the 2022 ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...